Rectal Microbiome Diversity Predicts Disease Response at Completion of Radiation Therapy for Squamous Cell Carcinoma of the Cervix

Lauren E. Colbert(The University of Texas MD Anderson Cancer Center), Ann H. Klopp(The University of Texas MD Anderson Cancer Center), A. Jhingran(The University of Texas MD Anderson Cancer Center), Nadim J. Ajami(Baylor College of Medicine), R. Previs(The University of Texas MD Anderson Cancer Center), Patricia J. Eifel(The University of Texas MD Anderson Cancer Center), Andrea Y. Delgado Medrano(The University of Texas MD Anderson Cancer Center), Lois M. Ramondetta(The University of Texas MD Anderson Cancer Center), Pablo C. Okhuysen(The University of Texas MD Anderson Cancer Center), Michael Frumovitz(The University of Texas MD Anderson Cancer Center), J. F. Petrosino(Baylor College of Medicine), S.M. Hahn(The University of Texas MD Anderson Cancer Center), Amir A. Jazaeri(The University of Texas MD Anderson Cancer Center), K. Schmeler(The University of Texas MD Anderson Cancer Center), Diane Hutchinson(Baylor College of Medicine)
International Journal of Radiation Oncology*Biology*Physics
September 23, 2017
10.1016/j.ijrobp.2017.06.129
Cited by 7

Related Papers

Breast cancer classification and prognosis based on gene expression profiles from a population-based study
|Proceedings of the National Academy of Sciences|2003|2k
The human gut microbiome in early-onset type 1 diabetes from the TEDDY study
|Nature|2018|902
Concise Review: Dissecting a Discrepancy in the Literature: Do Mesenchymal Stem Cells Support or Suppress Tumor Growth?
|Stem Cells|2010|571
Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance
|Nature Medicine|2023|508
Near-infrared fluorescence for detection of sentinel lymph nodes in women with cervical and uterine cancers (FILM): a randomised, phase 3, multicentre, non-inferiority trial
|The Lancet Oncology|2018|342